Cognitive Impairment Due to Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Cognitive Impairment Due to Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: [18F]APN-1607 PET in Subjects With AD Compared to HC [Phase 3]
A Phase 3 study evaluating the PET radiotracer [18F]APN-1607 in Alzheimer's disease and mild cognitive impairment due to Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Biomarkers of Cognitive Impairment in Blood Cells
A completed clinical trial from the University of the Balearic Islands studied blood-cell biomarkers of cognitive impairment linked to Alzhe…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects [Phase 2]
Phase 2 clinical trial evaluating [18F]APN-1607 PET uptake in Alzheimer's disease patients versus healthy subjects; status currently unknown…
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset [Phase 3]
Phase 3 trial evaluating pioglitazone for delaying onset of mild cognitive impairment due to Alzheimer's disease; trial terminated with resu…
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease [Phase 3]
Phase 3 extension study evaluating pioglitazone for slowing cognitive decline in mild cognitive impairment due to Alzheimer's disease; study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration [Phase 1, Phase 2]
A clinical trial investigating probucol-induced apoE to mitigate cognitive deterioration has completed Phase 1 and Phase 2 studies focused o…